Avalo Therapeutics, Inc. · NASDAQ:AVTX

Affinity Asset Advisors, LLC reported a 7.65% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 13, 2025

Affinity Asset Advisors, LLC reported a 7.65% stake in Avalo Therapeutics, Inc., 1,006,217 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).

Stake
7.65%
Shares
1,006,217
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Healthcare Fund, LP7.65%1,006,217
Affinity Asset Advisors, LLC7.65%1,006,217

Source

View original at SEC

Related